The microfluidic multiplex biosensor carries proteins attached to a polymer film that recognize the antibiotics.
Photo: Patrick Seeger
Freiburg researchers are testing a biosensor for personalized dosing of medications.
A team of engineers and biotechnologists at the University of Freiburg has for the first time shown in mammals that the concentration of antibiotics in the body can be determined using breath samples. The breath measurements also corresponded to the antibiotic concentrations in the blood. The team’s biosensor – a multiplex chip that allows simultaneous measurement of several specimens and test substances – will in future enable personalized dosing of medicines against infectious diseases on-site and help to minimize the development of resistant strains of bacteria.
The sensor developed by the research group headed by Dr. Can Dincer and H. Ceren Ates, FIT Freiburg Center for Interactive Materials and Bioinspired Technologies, and Prof. Dr. Wilfried Weber, Professor of Synthetic Biology and a member of the team of speakers at the Cluster of Excellence CIBSS – Centre for Integrative Biological Signalling Studies, is based on synthetic proteins that react to antibiotics and thus generate a current change. The researchers’ results are now being published in the journal Advanced Materials.
Previously researchers could only detect traces of antibiotics in the breath
The researchers tested the biosensor on the blood, plasma, urine, saliva and breath samples of pigs who had received antibiotics. They were able to show that the result achieved with biosensors in the pigs’ plasma were as accurate as the standard medical laboratory process. Previously, measurement of antibiotic levels in exhaled breath samples was not possible: “Until now researchers could only detect traces of antibiotics in the breath. With our synthetic proteins on a microfluidic chip, we can determine the smallest concentrations in the breath condensate and they correlate with the blood values,” explains Dincer.
Sensor will help to keep antibiotic level stable in severely ill
Physicians need to keep the antibiotics level within a personalized therapeutic range for patients suffering severe infections, at the risk of threats such as sepsis and organ failure or even the death of the patient. Inadequate administration of antibiotics could allow bacteria to mutate so that the medicines no longer work: they become resistant. “Rapid monitoring of antibiotic levels would be a huge advantage in hospital,” says Ates, “it might be possible to fit the method into a conventional face mask.” In another project at the University of Freiburg, Dincer is developing wearable paper sensors for the continuous measurement of biomarkers from exhaled breath. Clinical trials to validate the antibiotic biosensor by testing the system with human samples are planned.
Bacterial proteins as sensor
The microfluidic biosensor bears proteins that can recognize beta-lactam antibiotics such as penicillin, affixed to a polymer film. Antibiotic of interest in the sample and an enzyme-coupled beta-lactam are in competition to bind these bacterial proteins. This competition generates a current change – like in a battery: the more antibiotic there is present in the sample, the less enzyme product develops, which leads to a lower measurable current. The process is based on a natural receptor protein that resistant bacteria uses to detect the antibiotics that threatens them. “You could say we are beating the bacteria at their own game,” Weber says of the process developed by his group.
Original Article: Antibiotic levels measurable in breath for first time
More from: University of Freiburg
The Latest on: Microfluidic biosensor
- Metamaterials Used for Quantitative Analysis in Paper-based Diagnosticson June 27, 2022 at 5:01 pm
Paper-based microfluidic diagnostics hold promise as ... While most paper-based biosensors – usually a strip of paper doped with an antibody specific to an antigen of interest – use ...
- Graphene Sensor Inside Microfluidic Chip Detects Bacteria in Tiny Sampleson June 25, 2022 at 5:00 pm
pylori which is known to cause stomach ulcers. They created a new biosensor that uses microfluidics to position tiny droplets of a sample on top of a graphene component. The graphene was covered ...
- Flexing the Power of a Conductive Polymeron June 23, 2022 at 7:36 am
In the recent paper, chemistry professor Thuc-Quyen Nguyen, who leads the UCSB Center for Polymers and Organic Solids, and co-authors including Visell describe a breakthrough material — a soft, ...
- Tackling Respiratory Infections in the 21st Centuryon June 22, 2022 at 9:06 am
Recent advances include lab-on-a-chip (LOC) technologies that use microfluidic components with biosensors to carry out a complex test with rapidity and specificity, using tiny amounts of reagent ...
- Microfluidics Market Demand and Future Growth Explored in Latest Research Report By 2030on June 16, 2022 at 5:57 am
Additionally, microfluidics with advanced plasmonic biosensor technology is expected to improve POC testing. Microfluidics-based plasmonic biosensors offer a high-throughput platform for ...
- Ovarian cancer biomarkers for molecular biosensors and translational medicineon June 14, 2022 at 5:00 pm
The future expects high-throughput automated assay platforms for microfluidic (i.e., biofluid ... specific clinical end points of interest. Biosensors are expected to be miniaturized for point ...
- The First 3D Printer for Microfluidic Devices Allows One-Step Prototypingon June 7, 2022 at 5:01 pm
The evolving field of microfluidics has strong commercial potential, particularly for analytical applications such as biochemical analysis, biosensors, and biochemical assay development. Some chemical ...
- Cooperation with Fraunhoferon May 27, 2022 at 10:34 am
At its core is a microfluidic chip that is equipped with a biosensor. To do this, the Snifits4Health team combines knowledge from microfluidics, optics, synthetic chemistry, and protein engineering.
- Microfluidics Market is Expected to Reach US$ 17.8 Bn by 2031 | Microfluidics Industry Size, Share, Trends and Forecaston May 12, 2022 at 8:33 am
availability and low costs of miniaturized biosensors have huge commercial potential. Strategic collaborations among key players drive the microfluidics market to develop novel microfluidic platforms ...
- ShadowAuxin: Optimization of Quenching FRET Pairs for a Fluorescent Auxin Biosensoron August 11, 2021 at 9:19 pm
We are working to build and test a novel auxin biosensor, ShadowAuxin, capable of accurate quantification and tracking of auxin in live plants. Our biosensor design relies on the dimerization of two ...
via Bing News
The Latest on: Microfluidic biosensor
via Google News